FDA Inspection 709497 — Ther-RX Corporation

Ther-RX Corporation — FEI 3004839832

The FDA completed an inspection of Ther-RX Corporation on Feb 11, 2011 in Chesterfield, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 11, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chesterfield, MO (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
135821 CFR 211.100(b)SOPs not followed / documented
136121 CFR 211.100(a)Absence of Written Procedures
202821 CFR 211.192Extent of discrepancy, failure investigations
440221 CFR 211.192Written record of investigation incomplete